Equity Capital Markets

Stifel ECM delivers a full suite of equity and equity linked products including IPOs, Follow-ons, Converts and SPACs across all of our focus sectors

Equity Capital Markets Group

Industry-Leading Full-Service Equity Capital Markets Group

The Equity Capital Markets Group (ECM) is responsible for originating and executing public and private equity and equity linked offerings as well as SPACs. In 2021, the ECM group managed over 265 equity and equity-linked transactions, including executing 76 IPOs, raising more than $108B. In addition, the ECM team has a leading SPAC business, advising in 2021 on more than 45 transactions within all phases of the Special Purpose Acquisition Company (SPAC) lifecycle, including IPOs, PIPEs, and de-SPAC engagements. The Stifel equity platform brings differentiated institutional access and retail distribution in the US and Internationally.

Stifel is named U.S. Mid-Market Equity House of the Year by International Financing Review

Learn More

Notable Transactions

$ 460,000,000

Follow-on Offering

Joint Bookrunner

Biopharma | March 2023

$ 65,000,000

Preferred Stock

Joint Bookrunner

Transportation & Logistics | March 2023

C$ 17,500,000

Follow-on Offering

Sole Bookrunner

Energy | March 2023

$ 1,220,000,000

Mergers & Acquisitions

Capital Markets Advisor

Food & Beverage | February 2023

$ 230,000,000

Follow-on Offering

Joint Bookrunner

Specialty Distribution, Building Products | February 2023

$ 163,000,000

Follow-on Offering

Joint Global Coordinator and Joint Bookrunner

Energy | February 2023

$ 189,400,000

Follow-on Offering

Joint Bookrunner

Real Estate | February 2023

$ 220,800,000

Initial Public Offering

Joint Bookrunner

Biopharma | February 2023

$ 504,000,000

Mergers & Acquisitions

Advisor to Seller

Electronics & Industrial Technology | February 2023

$ 20,300,000

PIPE

Sole Placement Agent and Nomad

Healthcare | February 2023

$ 100,000,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Medtech | February 2023

$ 19,940,000

Confidentially Marketed Follow-on Offering

Sole Bookrunner

Electronics & Industrial Technology | January 2023

$ 227,843,965

Follow-on Offering

Joint Bookrunner

Biopharma | January 2023

$ 120,000,000

Convertible Notes

Left Bookrunner

Medtech | December 2022

$ 115,799,748

Registered Direct & PIPE

Joint Bookrunner & Joint Placement Agent

Biopharma | December 2022

$ 65,010,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | December 2022

$ 300,375,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | December 2022

$ 44,664,988

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Electronics & Industrial Technology | November 2022

$ 62,000,000

Follow-on Offering

Joint Bookrunner

Aerospace, Defense & Government Services | November 2022

$ 850,000,000

Mergers & Acquisitions

Financial and Capital Markets Advisor

Biopharma | November 2022

$ 115,000,000

Follow-on Offering

Joint Bookrunner

Medtech | October 2022

£ 64,000,000

Convertible Bond & Follow-on Offering

Sole Bookrunner, Sole Placement Agent, Sole Broker and Nomad

Healthcare Services | October 2022

C$ 175,005,000

Follow-on Offering

Co-Lead Manager

Metals & Mining | October 2022

$ 75,000,000

Senior Secured Notes

Joint Placement Agent

Industrial & Environmental Services | October 2022

$ 80,000,000

PIPE

Joint Placement Agent

Industrial & Environmental Services | October 2022

£ 10,482,996

Placing and Subscription

Broker and Sole Bookrunner

Internet & Digital Media | October 2022

$ 220,000,000

Follow-on Offering

Joint Broker and Joint Bookrunner

Technology | September 2022

Follow-on Offering

Joint Global Coordinator and Joint Bookrunner

Energy & Natural Resources | September 2022

$ 58,079,577

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | September 2022

$ 69,750,000

Follow-on Offering

Joint Bookrunner

Food & Beverage | September 2022

$ 124,800,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | September 2022

$ 1,085,600,000

Business Combination

Lead Financial & Capital Markets Advisor

Food & Beverage | August 2022

$ 658,000,000

Mergers & Acquisitions

Advisor to Seller

Internet & Digital Media | August 2022

$ 84,309,375

Follow-on Offering

Joint Bookrunner

Aerospace, Defense & Government Services | August 2022

$ 84,249,986

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | August 2022

$ 143,893,750

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Medtech | August 2022

$ 862,500,000

Follow-on Offering

Lead Manager

Biopharma | August 2022

$ 1,308,000,000

Mergers & Acquisitions

Advisor to Seller

Software | August 2022

$ 338,750,000

Mergers & Acquisitions

Advisor to Buyer

Software | August 2022

$ 181,800,000

Follow-on Offering

Joint Bookrunner

Real Estate | August 2022

$ 550,000,000

Has Received a Minority Investment from

Advisor to Seller

Consumer Products | August 2022

€ 30,000,000

Initial Public Offering

Joint Global Coordinator and Euronext Growth Advisor

Energy & Natural Resources | July 2022

$ 104,500,000

Senior Secured Term Loan

Sole Placement Agent

Medtech | July 2022

$ 55,300,000

Exchange of Convertible Notes

Sole Bookrunner

Medtech | July 2022

$ 250,000,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Healthtech | June 2022

C$ 5,010,000

Follow-on Offering

Left Bookrunner

Metals & Mining | June 2022

C$ 7,287,000

Follow-on Offering

Sole Bookrunner

Consumer & Retail | June 2022

C$ 20,000,000

Follow-on Offering

Left Bookrunner

Metals & Mining | June 2022

C$ 17,047,000

Convertible Notes

Co-Manager

Energy | May 2022

£ 34,261,864

Follow-on Offering

Joint Bookrunner

Biopharma | May 2022

C$ 34,511,565

Follow-on Offering

Joint Bookrunner

Healthtech | May 2022

$ 108,000,000

Initial Public Offering

Joint Bookrunner

Biopharma | May 2022

$ 350,000,000

Follow-on Offering

Joint Bookrunner

Consumer Products | May 2022

£ 300,000,000

Follow-on Offering

Sole Sponsor, Financial Adviser, Global Coordinator, Bookrunner

Real Estate | April 2022

$ 200,000,000

Initial Public Offering

Joint Bookrunner

Biopharma | April 2022

$ 230,000,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | April 2022

$ 149,500,000

Follow-on Offering

Joint Bookrunner

Specialty Distribution, Building Products | April 2022

€ 15,000,000

Follow-on Offering

Joint Global Coordinator and Joint Bookrunner

Healthcare | April 2022

$ 30,000,000

Convertible Bond and Equity Placing

Sole Financial Advisor and Sole Placement Agent

Medtech | March 2022

$ 230,000,000

Follow-on Offering

Joint Bookrunner

Biopharma | March 2022

$ 75,000,000

Confidentially Marketed Follow-on Offering

Left Bookrunner

Biopharma | March 2022

C$ 32,343,743

Follow-on Offering

Joint Bookrunner

Consumer & Retail | March 2022

C$ 25,311,500

Follow-on Offering

Co-Manager

Energy | March 2022

$ 230,000,000

Initial Public Offering

Joint Bookrunner

Capital Goods | March 2022

$ 1,440,000,000

SPAC Merger

Financial Advisor

Capital Goods | February 2022

$ 1,052,000,000

Mergers & Acquisitions

Capital Markets Advisor

Internet & Digital Media | February 2022

$ 85,000,000

Initial Public Offering

Joint Bookrunner

Consumer Products | February 2022

C$ 200,000,000

Senior Notes

Co-Manager

Energy | February 2022

$ 100,000,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | January 2022

$ 200,000,000

Initial Public Offering

Joint Bookrunner

Electronics & Industrial Technology | January 2022

C$ 33,532,415

Follow-on Offering

Co-Manager

Metals & Mining | January 2022

£ 130,000,000

Follow-on Offering

Joint Bookrunner

Diversified Industrials | January 2022

$ 390,320,000

Follow-on Offering

Joint Bookrunner

Real Estate | January 2022

C$ 42,542,500

Follow-on Offering

Co-Manager

Metals & Mining | January 2022

$ 200,300,000

Follow-on Offering

Joint Bookrunner

Real Estate | January 2022

C$ 195,000,000

Fairness Opinion

Advisor to the Special Committee of the Board of Fiore Gold

Metals & Mining | January 2022

$ 98,000,000

Initial Public Offering

Joint Bookrunner

Biopharma | January 2022

$ 1,500,000,000

Mergers & Acquisitions

Joint Financial Advisor

Electronics & Industrial Technology | December 2021

$ 70,000,000

PIPE

Joint Placement Agent

Electronics & Industrial Technology | December 2021

$ 200,000,000

SPAC IPO

Sole Bookrunner

Automotive Aftermarket | December 2021

$ 180,000,000

Follow-on Offering

Joint Bookrunner

Internet & Digital Media | December 2021

$ 1,239,000,000

Mergers & Acquisitions

Advisor to Seller

Electronics & Industrial Technology | December 2021

$ 52,325,000

Follow-on Offering

Joint Bookrunner

Biopharma | December 2021

$ 41,000,000

Bookrunner, Global Coordinator and Nomad

Technology | November 2021

C$ 230,071,000

Follow-on Offering

Co-Manager

Energy | November 2021

C$ 65,000,000

Convertible Notes

Co-Lead Manager

Healthtech | November 2021

$ 172,500,000

SPAC IPO

Left Bookrunner

Biopharma | November 2021

C$ 20,000,000

Convertible Debentures

Sole Bookrunner

Diversified Industries | November 2021

C$ 22,000,000

Follow-on Offering

Sole Bookrunner

Diversified Industries | November 2021

$ 105,000,000

Follow-on Offering

Joint Bookrunner

Engineering & Construction, and Infrastructure | November 2021

$ 72,250,000

Follow-on Offering

Joint Bookrunner

Real Estate | November 2021

$ 80,500,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Medtech | November 2021

$ 43,000,000

Private Placement

Lead Placement Agent

Biopharma | November 2021

$ 100,800,000

Follow-on Offering

Joint Bookrunner

Tools & Diagnostics | November 2021

$ 300,000,000

Follow-on Offering

Joint Bookrunner

Tech-Enabled Services | November 2021

C$ 26,101,250

Follow-on Offering

Joint Bookrunner

Metals & Mining | November 2021

$ 350,000,000

Mergers & Acquisitions

Exclusive Financial Advisor & Capital Markets Advisor

Gaming & Leisure | November 2021

$ 450,000,000

Follow-on Offering

Joint Bookrunner

Electronics & Industrial Technology | November 2021

C$ 100,020,000

Private Placement

Sole Bookrunner

Technology | November 2021

$ 158,000,000

Mergers & Acquisitions

Capital Markets Advisor

Healthtech | November 2021

C$ 25,875,000

Follow-on Offering

Joint Bookrunner

Energy | November 2021

$ 230,000,000

Initial Public Offering

Joint Bookrunner

Healthcare Services | November 2021

$ 93,600,000

Initial Public Offering

Joint Bookrunner

Medtech | October 2021

$ 422,000,000

Initial Public Offering

Joint Bookrunner

Tech-Enabled Services | October 2021

$ 74,250,000

Follow-on Offering

Joint Bookrunner

Consumer Products | October 2021

$ 150,750,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | October 2021

C$ 49,831,250

Follow-on Offering

Left Bookrunner

Metals & Mining | October 2021

£ 200,000,000

Follow-on Offering

Sole Bookrunner and Financial Adviser

Real Estate | October 2021

£ 50,000,000

Follow-on Offering

Joint Bookrunner

Diversified Industrials | October 2021

C$ 7,004,400

Follow-on Offering

Joint Bookrunner

Life Sciences & Healthcare | October 2021

$ 74,865,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Medtech | October 2021

C$ 17,307,500

Follow-on Offering

Joint Bookrunner

Consumer & Retail | October 2021

C$ 5,949,680

Private Placement

Co-Lead Agent

Metals & Mining | October 2021

$ 165,000,000

SPAC Initial Public Offering

Left Bookrunner

Consumer Products | October 2021

$ 175,000,000

Initial Public Offering

Sole Bookrunner

Electronics & Industrial Technology | October 2021

$ 250,000,000

Initial Public Offering

Joint Bookrunner

Consumer Products | October 2021

$ 345,000,000

Follow-on Offering

Joint Bookrunner

Medtech | October 2021

C$ 173,052,000

Follow-on Offering

Co-Manager

Energy | October 2021

$ 195,801,300

Initial Public Offering

Joint Bookrunner

Consumer Products | October 2021

$ 155,000,000

Follow-on Offering

Joint Bookrunner

Engineering & Construction, and Infrastructure | September 2021

$ 328,600,000

Initial Public Offering

Joint Bookrunner

Tech-Enabled Services | September 2021

$ 410,000,000

SPAC M&A

Advisor to Seller

Electronics & Industrial Technology | September 2021

$ 13,200,000

Follow-on Offering

Joint Bookrunner

Healthcare Services | September 2021

$ 354,000,000

Follow-on Offering

Joint Bookrunner

Technology | September 2021

$ 1,000,000,000

Follow-on Offering

Joint Bookrunner

Biopharma | September 2021

£ 125,000,000

Follow-on Offering

Joint Bookrunner and Financial Adviser

Real Estate | September 2021

$ 651,000,000

SPAC Merger

Capital Markets Advisor

Tools & Diagnostics | September 2021

C$ 108,150,000

Follow-on Offering

Co-Manager

Energy | August 2021

$ 4,100,000,000

Has Merged with

Capital Markets Advisor

Aerospace, Defense & Government Services | August 2021

$ 212,000,000

SPAC Merger & PIPE

Capital Markets Advisor

Biopharma | August 2021

$ 355,810,000

Initial Public Offering

Joint Bookrunner

Biopharma | August 2021

$ 84,333,337

Initial Public Offering

Joint Bookrunner

Biopharma | July 2021

$ 424,000,000

Initial Public Offering

Joint Bookrunner

Consumer Products | July 2021

$ 42,000,000

Initial Public Offering

Joint Bookrunner

Gaming & Leisure | July 2021

$ 230,000,000

Initial Public Offering

Joint Bookrunner

Tools & Diagnostics | July 2021

£ 17,000,000

Initial Public Offering

Sole Global Coordinator, Joint Bookrunner & Nomad

Healthtech | July 2021

$ 174,560,000

Initial Public Offering

Joint Bookrunner

Biopharma | July 2021

$ 1,664,000,000

Mergers & Acquisitions

Financial Advisor and Capital Markets Advisor

Electronics & Industrial Technology | July 2021

$ 2,642,000,000

Mergers & Acquisitions

Capital Markets Advisor

Specialty Distribution | July 2021

$ 180,132,080

Initial Public Offering

Joint Bookrunner

Tools & Diagnostics | July 2021

$ 62,675,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Medtech | July 2021

$ 100,190,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | July 2021

$ 350,000,000

Follow-on Offering

Joint Bookrunner

Biopharma | July 2021

$ 325,000,000

Initial Public Offering

Joint Bookrunner

Software | July 2021

$ 97,807,500

Initial Public Offering (U.S. Nasdaq)

Joint Bookrunner

Medtech | July 2021

$ 160,000,000

Initial Public Offering

Joint Bookrunner

Biopharma | June 2021

$ 409,200,000

Initial Public Offering

Joint Bookrunner

Internet & Digital Media | June 2021

$ 409,200,000

Initial Public Offering

Joint Bookrunner

Internet & Digital Media | June 2021

$ 100,000,000

Preferred Stock

Left Bookrunner

Real Estate | June 2021

$ 160,000,000

Initial Public Offering

Joint Bookrunner

Biopharma | June 2021

$ 80,000,000

Follow-on Offering

Left Bookrunner

Entertainment | June 2021

$ 150,000,000

Initial Public Offering

Sole Bookrunner

Entertainment | June 2021

$ 128,600,000

Initial Public Offfering

Joint Global Coordinator and Joint Bookrunner

Internet & Digital Media | June 2021

$ 400,000,000

Senior Notes

Co-Manager

Energy | June 2021

$ 249,700,000

Follow-on

Joint Bookrunner

Consumer Products | June 2021

$ 96,000,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Electronics & Industrial Technology | June 2021

C$ 100,000,000

Follow-on Offering

Co-Lead Manager

Metals & Mining | June 2021

C$ 20,000,000

Follow-on Offering

Sole Bookrunner

Metals & Mining | June 2021

C$ 6,000,000

Private Placement

Joint Bookrunner

Metals & Mining | June 2021

$ 49,840,000

Follow-on Offering

Joint Bookrunner

Real Estate | June 2021

C$ 46,004,990

Follow-on Offering

Sole Bookrunner

Consumer Products | May 2021

$ 225,000,000

Follow-on Offering

Joint Global Coordinator

Energy & Natural Resources | May 2021

C$ 175,000,000

Follow-on Offering

Joint Bookrunner

Real Estate | May 2021

C$ 201,254,750

Follow-on Offering

Co-Manager

Energy | May 2021

C$ 75,000,000

Follow-on Offering

Joint Bookrunner

Building Products | April 2021

$ 98,325,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | April 2021

$ 100,912,500

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Medtech | April 2021

$ 72,680,000

Initial Public Offering

Left Bookrunner

Packaging, Specialty Distribution | April 2021

Follow-on Offering

Joint Bookrunner

Real Estate | April 2021

$ 287,500,000

Follow-on Offering

Joint Bookrunner

Biopharma | April 2021

$ 177,023,991

Follow-on Offering

Joint Bookrunner

Real Estate | April 2021

$ 646,875,000

Follow-on Offering

Joint Bookrunner

Tools & Diagnostics | April 2021

$ 550,000,000

Convertible Senior Notes

Joint Bookrunner

Biopharma | April 2021

£ 7,454,727

Follow-on Offering

NOMAD and Sole Bookrunner

Software | March 2021

$ 103,500,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | March 2021

$ 50,652,000

Confidentially Marketed Follow-on Offering

Left Bookrunner

Biopharma | March 2021

$ 30,000,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | March 2021

$ 75,000,000

Preferred Stock

Left Bookrunner

Energy & Natural Resources | March 2021

$ 48,000,000

Follow-on Offering

Joint Bookrunner

Biopharma | March 2021

$ 56,000,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | March 2021

$ 99,750,000

Follow-on Offering

Joint Bookrunner

Real Estate | March 2021

$ 160,425,000

Follow-on Offering

Joint Bookrunner

Biopharma | March 2021

$ 138,250,000

Convertible Notes

Sole Bookrunner

Medtech | March 2021

$ 42,000,000

Confidentially Marketed Follow-on Offering

Sole Bookrunner

Medtech | February 2021

$ 512,000,000

Initial Public Offering

Co-Manager

Financial Institutions & Financial Technology | January 2021

$ 400,000,000

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Metals & Mining | January 2021

$ 210,000,000

Private Placement

Sole Placement Agent

Real Estate | December 2020

$ 323,250,000

Private Investment in Public Equity

Joint Placement Agent

Electronics & Industrial Technology | December 2020

$ 276,000,000

Initial Public Offering

Joint Bookrunner

Software | December 2020

$ 555,450,000

Initial Public Offering

Joint Bookrunner

Biopharma | December 2020

Initial Public Offering

Joint Bookrunner

Cannabis | December 2020

$ 172,500,000

Follow-on Offering

Joint Bookrunner

Cannabis | December 2020

$ 275,000,000

Initial Public Offering

Joint Bookrunner

Software | December 2020

$ 56,600,000

Block Trade

Joint Bookrunner

Energy & Natural Resources | December 2020

$ 45,325,000

Block Trade

Left Bookrunner

Metals & Mining | December 2020

$ 200,000,000

Follow-on Offering

Joint Bookrunner

Biopharma | December 2020

$ 345,080,500

Follow-on Offering

Joint Bookrunner

Biopharma | December 2020

$ 312,225,000

Follow-on Offering

Joint Bookrunner

Tools & Diagnostics | December 2020

$ 750,000,000

Follow-on Offering

Joint Bookrunner

Tools & Diagnostics | December 2020

$ 277,725,000

Initial Public Offering

Joint Bookrunner

Biopharma | December 2020

€ 134,071,417

Follow-on Offering

Joint Bookrunner

Industrial & Environmental Services | November 2020

$ 93,987,050

Initial Public Offering

Left Bookrunner

Gaming & Leisure | November 2020

$ 68,425,000

Follow-on Offering

Joint Bookrunner

Electronics & Industrial Technology | November 2020

$ 151,250,000

Follow-on Offering

Joint Bookrunner

Food & Beverage | November 2020

€ 30,000,000

Follow-on Offering

Joint Bookrunner

Business Services | November 2020

$ 333,500,000

Follow-on Offering

Joint Bookrunner

Gaming & Leisure | November 2020

$ 1,863,000,000

Initial Public Offering

Joint Bookrunner

Tools & Diagnostics | November 2020

$ 81,176,464

Initial Public Offering

Joint Bookrunner

Biopharma | November 2020

C$ 263,128,000

Initial Public Offering

Co-Manager

Energy | October 2020

$ 55,000,000

Follow-on Offering

Joint Bookrunner

Real Estate | October 2020

$ 345,000,000

Initial Public Offering

Lead Manager

Medtech | October 2020

Follow-on Offering

Co-Lead Manager

Cannabis | June 2020

$ 79,347,051

Confidentially Marketed Follow-on Offering

Joint Bookrunner

Biopharma | March 2020

$ 35,000,000

Follow-on Offering

Joint Bookrunner

Energy & Natural Resources | March 2016

Currency volume represents full credit to each underwriter. All transaction announcements appear as a matter of record only. Stifel collectively refers to Stifel, Nicolaus & Company, Incorporated and other affiliated broker-dealer subsidiaries of Stifel Financial Corp.